🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 1-year, open-label, long-term safety extension for patients who h...
Status
Completed
Location
Kyowa Pharmaceutical Inc.
Start Date
2004-10
Trial ID
NCT00199368
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of 40 mg a day of ist...
Status
Completed
Location
Kyowa Hakko UK Ltd.
Start Date
2004-11
Trial ID
NCT00199394
Treatments Being Tested
To establish the efficacy of 10, 20 and 40 mg/d dose of istradefylline for ...
Status
Completed
Location
Kyowa Pharmaceutical Inc.
Start Date
2004-07
Trial ID
NCT00199420
Treatments Being Tested
To establish the efficacy of 20 mg/day and 40 mg/day doses of istradefyllin...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00199355
Treatments Being Tested
The purpose of this study is to test whether mild liver impairment affects ...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2014-08
Trial ID
NCT02256033
Treatments Being Tested
This is an investigator-initiated trial. In this 6-month open label, single...
Status
Completed
Location
Georgetown University Hospital
Start Date
2023-01-20
Trial ID
NCT05885360
Treatments Being Tested
The primary objective of this study was to establish the long-term tolerabi...
Status
Completed
Location
48 Centers in the US and 4 in Canada
Start Date
2002-08
Trial ID
NCT00955045
Treatments Being Tested
This study is testing a new oral medication called VG081821AC to see if it ...
Status
Recruiting
Location
Xuanwu Hospital of Capital Medical University
Start Date
2026-07-17
Trial ID
NCT07725562
Treatments Being Tested
The purpose of this study is to establish the efficacy of 20 mg/day and 40 ...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00955526
Treatments Being Tested
The purpose of this study is to confirm the long term tolerability and safe...
Status
Completed
Location
The University of Chicago
Start Date
2005-03
Trial ID
NCT00203957
Treatments Being Tested